PJMHS 2022
DOI: 10.53350/pjmhs22169250
|View full text |Cite
|
Sign up to set email alerts
|

Superiority of the Hyperbaric Bupivacaine 0.50% Over 0.75% Hyperbaric Bupivacaine in patients Undergoing Electivecesarean Section: A Uni-Center Double Blind Randomized Control Trial

Abstract: Objective: The objective of this study was to compare 0.75% and 0.50% hyperbaric bupivacaine in terms of hemodynamic stability in elective cesarean section. Study Design: Randomized Controlled Trial. Place and duration: Department of Anesthesiology, Intensive care and pain management, Combined Military Hospital, Mardan from September 2021 to March 2022. Methodology: Total 104 women were randomly divided into Group-A (0.50% drug concentration) and Group-B (0.75% drug concentration) hyperbaric bupivacaine. Bas… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 10 publications
(12 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?